Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Ezetimibe: Likely to Be Beneficial For All.

Journal article

Herrington WG. et al, (2018), Circulation, 137, 1583 - 1584

Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study.

Journal article

Parish S. et al, (2018), Circ Genom Precis Med, 11

The Role of Emerging Risk Factors in Cardiovascular Outcomes.

Journal article

Lacey B. et al, (2017), Curr Atheroscler Rep, 19

Factors influencing recruitment in large randomised trials

Conference paper

Edwards D. et al, (2017), TRIALS, 18

Safety and efficacy of statins reply

Journal article

Collins R. et al, (2017), LANCET, 389, 1099 - 1100

Interpretation of the evidence for the efficacy and safety of statin therapy.

Journal article

Collins R. et al, (2016), Lancet (London, England)

Lessons from the controversy over statins - Authors' reply.

Journal article

Armitage J. et al, (2016), Lancet, 388, 2237 - 2238

The Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin with Laropiprant on Health and Healthcare Costs

Journal article

Mihaylova BN. et al, (2016), Circulation: Cardiovascular Quality and Outcomes

Protocol for analyses of adverse event data from randomized controlled trials of statin therapy

Journal article

Reith C. et al, (2016), American Heart Journal, 176, 63 - 69

Load More +